Have a personal or library account? Click to login
Safety and efficacy of non–vitamin K antagonist oral anticoagulants compared with well-controlled warfarin in Thai patients with atrial fibrillation Cover

Safety and efficacy of non–vitamin K antagonist oral anticoagulants compared with well-controlled warfarin in Thai patients with atrial fibrillation

Asian Biomedicine
Volume 16 (2022): Issue 3 (June 2022)
By: Janekij Yamkasikorn and  Komsing Methavigul  
Open Access
|Jun 2022

Authors

Janekij Yamkasikorn

Department of Cardiology, Central Chest Institute of Thailand, Nonthaburi, Thailand

Komsing Methavigul

komsing@ccit.mail.go.th

Department of Cardiology, Central Chest Institute of Thailand, Nonthaburi, Thailand
DOI: https://doi.org/10.2478/abm-2022-0016 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Journal RSS Feed
Language: English
Page range: 131 - 136
Published on: Jun 30, 2022
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year
Keywords:
atrial fibrillation,
factor Xa inhibitors,
hemorrhage,
non–vitamin K antagonist oral anticoagulants,
warfarin
Related subjects:
Medicine,
Assistive professions, nursing,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Clinical medicine, other

© 2022 Janekij Yamkasikorn, Komsing Methavigul, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 16 (2022): Issue 3 (June 2022)Next article